You have free access to this content

American Journal of Transplantation

Cover image for Vol. 10 Issue 3

March 2010

Volume 10, Issue 3

Pages 438–706

  1. The AJT Report

    1. Top of page
    2. The AJT Report
    3. Editorials
    4. Minireview
    5. Meeting Reports
    6. Special Article
    7. Laboratory Science
    8. Clinical Science
    9. Brief Communication
    10. Case Reports
    11. Letters to the Editor
    1. You have free access to this content
      The AJT Report: News and issues that affect organ and tissue transplantation (pages 438–440)

      SUE PONDROM

      Article first published online: 16 FEB 2010 | DOI: 10.1111/j.1600-6143.2009.03057.x

      • image

      This month, in another special expanded edition of “The AJT Report,” we examine the improvements in intestinal graft survival, and explore why more of these transplants aren't done. We also take a look at the outcomes of the Banff Conference on Allograft Pathology, and at a new organ allocation law in Israel.

  2. Editorials

    1. Top of page
    2. The AJT Report
    3. Editorials
    4. Minireview
    5. Meeting Reports
    6. Special Article
    7. Laboratory Science
    8. Clinical Science
    9. Brief Communication
    10. Case Reports
    11. Letters to the Editor
    1. You have free access to this content
      Belatacept: The Promises and Challenges of Belatacept and Costimulatory Blockade (pages 441–442)

      B. Kaplan

      Article first published online: 16 FEB 2010 | DOI: 10.1111/j.1600-6143.2010.03026.x

      The publication of the belatacept phase III studies offers a challenge in balancing benefits such as reduced burden of toxicity against risks such as EBV complications and more T cell mediated rejection. See articles by Vincenti et al on page 535 and Durrbach et al on page 547.

    2. You have free access to this content
      Making Sense of Desensitization (pages 443–444)

      H. M. Gebel and P. F. Halloran

      Article first published online: 3 FEB 2010 | DOI: 10.1111/j.1600-6143.2009.03004.x

      Several questions must be addressed to determine whether desensitization plus paired exchange is an appropriate strategy for renal transplantation. See minireview by Montgomery on page 449.

    3. You have free access to this content
      Antibody-Based Immunosuppression Following Liver Transplantation: The Plot Thickens (pages 445–446)

      J. K. Heimbach and M. R. Charlton

      Article first published online: 1 FEB 2010 | DOI: 10.1111/j.1600-6143.2009.02972.x

      The role of antibody-based immunosuppression in liver transplant recipients remains an area in which prospective trials are needed. See article by Moonka et al on page 590.

    4. You have free access to this content
      What Should Work, May Not (pages 447–448)

      A. D. Kirk

      Article first published online: 16 FEB 2010 | DOI: 10.1111/j.1600-6143.2010.03025.x

      When new agents such as bortezomib appear, it is important to maintain scientific rigor regarding off-label use of medications. See brief communication by Sberro-Soussan et al on page 681.

  3. Minireview

    1. Top of page
    2. The AJT Report
    3. Editorials
    4. Minireview
    5. Meeting Reports
    6. Special Article
    7. Laboratory Science
    8. Clinical Science
    9. Brief Communication
    10. Case Reports
    11. Letters to the Editor
    1. You have free access to this content
      Renal Transplantation Across HLA and ABO Antibody Barriers: Integrating Paired Donation into Desensitization Protocols (pages 449–457)

      Robert A. Montgomery

      Article first published online: 1 FEB 2010 | DOI: 10.1111/j.1600-6143.2009.03001.x

      • imageimageimage
      • image
      • image
      • image
      • image
      • image

      This article reviews the options available for crossing HLA and ABO incompatible barriers and the donor/recipient phenotypes that benefit from these modalities. See editorial by Gebel and Halloran on page 443.

  4. Meeting Reports

    1. Top of page
    2. The AJT Report
    3. Editorials
    4. Minireview
    5. Meeting Reports
    6. Special Article
    7. Laboratory Science
    8. Clinical Science
    9. Brief Communication
    10. Case Reports
    11. Letters to the Editor
    1. You have free access to this content
      Improving Organ Procurement Travel Practices in the United States: Proceedings from the Michigan Donor Travel Forum (pages 458–463)

      M. J. Englesbe, S. Shah, J. A. Cutler, R. Africano, R. Lynch, M. Seely, R. Hasz, M. L. Sweeney, J. Roberts, R. M. Merion and on behalf of the Michigan Donor Travel Forum

      Article first published online: 5 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02964.x

      This meeting explored opportunities to improve organ procurement travel practices in the United States, including aircraft standards, travel practices, and travel liability coverage.

    2. You have free access to this content
      Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups (pages 464–471)

      B. Sis, M. Mengel, M. Haas, R. B. Colvin, P. F. Halloran, L. C. Racusen, K. Solez, W. M. Baldwin III, E. R. Bracamonte, V. Broecker, F. Cosio, A. J. Demetris, C. Drachenberg, G. Einecke, J. Gloor, D. Glotz, E. Kraus, C. Legendre, H. Liapis, R. B. Mannon, B. J. Nankivell, V. Nickeleit, J. C. Papadimitriou, P. Randhawa, H. Regele, K. Renaudin, E. R. Rodriguez, D. Seron, S. Seshan, M. Suthanthiran, B. A. Wasowska, A. Zachary and A. Zeevi

      Article first published online: 29 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02987.x

      • image

      The 10th Banff Conference on Allograft Pathology held in Banff, Canada August 9–14, 2009 specifically focused on antibody mediated graft injury, and resulted in implementation of six Banff working groups to evaluate clinical relevance and reproducibility of potential changes to the Banff classification.

  5. Special Article

    1. Top of page
    2. The AJT Report
    3. Editorials
    4. Minireview
    5. Meeting Reports
    6. Special Article
    7. Laboratory Science
    8. Clinical Science
    9. Brief Communication
    10. Case Reports
    11. Letters to the Editor
    1. You have free access to this content
      Understanding Disparities in Transplantation: Do Social Networks Provide the Missing Clue? (pages 472–476)

      K. Ladin and D. W. Hanto

      Article first published online: 5 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02963.x

      • image

      This paper presents a novel application of social network analysis to transplantation, illustrating implications for disparities and future clinical interventions.

  6. Laboratory Science

    1. Top of page
    2. The AJT Report
    3. Editorials
    4. Minireview
    5. Meeting Reports
    6. Special Article
    7. Laboratory Science
    8. Clinical Science
    9. Brief Communication
    10. Case Reports
    11. Letters to the Editor
    1. Original Articles

      You have free access to this content
      Modulation of Brain Dead Induced Inflammation by Vagus Nerve Stimulation (pages 477–489)

      S. Hoeger, C. Bergstraesser, J. Selhorst, J. Fontana, R. Birck, R. Waldherr, G. Beck, C. Sticht, M. A. Seelen, W. J. Van Son, H. Leuvenink, R. Ploeg, P. Schnuelle and B. A. Yard

      Article first published online: 5 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02951.x

      • image
      • image
      • image
      • image
      • image
      • image

      Vagus nerve stimulation in brain-dead rats resulted in downregulation of a variety of pro-inflammatory cytokines in small intestine and kidney, inhibition of serum TNF α release, reduction of infiltrating monocytes in donor kidneys and transplanted kidneys, and improved renal function in recipients.

    2. You have free access to this content
      Alternative Macrophage Activation-Associated Transcripts in T-Cell-Mediated Rejection of Mouse Kidney Allografts (pages 490–497)

      K. S. Famulski, D. Kayser, G. Einecke, K. Allanach, D. Badr, J. Venner, B. Sis and P. F. Halloran

      Article first published online: 29 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02983.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image

      Accumulation of alternatively activated macrophages is a late process in rejection that is surprisingly independent of Th2 cytokines, and may be a consequence of severe tissue injury.

    3. You have free access to this content
      Inflammation and Epithelial to Mesenchymal Transition in Lung Transplant Recipients: Role in Dysregulated Epithelial Wound Repair (pages 498–509)

      L. A. Borthwick, E. I. McIlroy, M. R. Gorowiec, M. Brodlie, G. E. Johnson, C. Ward, J. L. Lordan, P. A. Corris, J. A. Kirby and A. J. Fisher

      Article first published online: 5 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02953.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image

      A hierarchy of pro-inflammatory cytokines exists that can dysregulate wound healing in lung epithelium via accentuation of TGF-beta1 effects.

    4. You have free access to this content
      Complement Independent Antibody-Mediated Endarteritis and Transplant Arteriopathy in Mice (pages 510–517)

      T. Hirohashi, S. Uehara, C. M. Chase, P. DellaPelle, J. C. Madsen, P. S. Russell and R. B. Colvin

      Article first published online: 5 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02958.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image

      After passive transfer of anti-class I MHC donor specific antibody, transplanted hearts developed chronic neointimal proliferation in coronary arteries without the participation of complement.

    5. You have free access to this content
      Recipient Dendritic Cells, But Not B Cells, Are Required Antigen-Presenting Cells for Peripheral Alloreactive CD8+ T-Cell Tolerance (pages 518–526)

      J. L. Mollov, C. L. Lucas, F. Haspot, J. Kurtz, C. Gaspar, A. Guzman and M. Sykes

      Article first published online: 1 FEB 2010 | DOI: 10.1111/j.1600-6143.2009.02967.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image

      Recipient dendritic cells are involved as APCs in tolerizing alloreactive CD8 cells in recipients of bone marrow transplantation treated with anti-CD40L mAb.

    6. You have free access to this content
      Decay Accelerating Factor is Essential for Successful Corneal Engraftment (pages 527–534)

      A. Esposito, B. Suedekum, J. Liu, F. An, J. Lass, M. G. Strainic, F. Lin, P. Heeger and M. E. Medof

      Article first published online: 5 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02961.x

      • image
      • image
      • image
      • image
      • image

      DAF is required for successful engraftment following corneal transplantation, suggesting that DAF is required for immune privilege of the corneal graft.

  7. Clinical Science

    1. Top of page
    2. The AJT Report
    3. Editorials
    4. Minireview
    5. Meeting Reports
    6. Special Article
    7. Laboratory Science
    8. Clinical Science
    9. Brief Communication
    10. Case Reports
    11. Letters to the Editor
    1. Original Articles

      You have free access to this content
      A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study) (pages 535–546)

      F. Vincenti, B. Charpentier, Y. Vanrenterghem, L. Rostaing, B. Bresnahan, P. Darji, P. Massari, G. A Mondragon-Ramirez, M. Agarwal, G. Di Russo, C.-S. Lin, P. Garg and C. P. Larsen

      Article first published online: 16 FEB 2010 | DOI: 10.1111/j.1600-6143.2009.03005.x

      • image
      • image

      In this Phase III trial, patients on belatacept-based immunosuppressive regimens had similar patient/graft survival, superior renal function, and a better cardiovascular/metabolic risk profile than patients treated with cyclosporine, despite experiencing a higher incidence of early acute rejection. See editorial by Kaplan on page 441.

    2. You have free access to this content
      A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT-EXT Study) (pages 547–557)

      A. Durrbach, J. M. Pestana, T. Pearson, F. Vincenti, V. D. Garcia, J. Campistol, M. Del Carmen Rial, S. Florman, A. Block, G. Di Russo, J. Xing, P. Garg and J. Grinyó

      Article first published online: 16 FEB 2010 | DOI: 10.1111/j.1600-6143.2010.03016.x

      • image
      • image

      In a Phase III trial in recipients of extended criteria donor kidneys, patients treated with belatacept-based immunosuppression achieved similar patient/graft survival, better renal function, and a better cardiovascular/metabolic profile but with a higher incidence of PTLD as compared to treatment with cyclosporine. See editorial by Kaplan on page 441.

    3. You have free access to this content
      The Outcome of Patients with Nephrogenic Systemic Fibrosis after Successful Kidney Transplantation (pages 558–562)

      N. Leung, A. Shaikh, F. G. Cosio, M. D. Griffin, S. C. Textor, J. M. Gloor, T. R. Schwab, T. S. Larson, P. G. Dean, M. Prieto, S. L. Nyberg, M. D. Stegall, C. U. Lee and M. R. Pittelkow

      Article first published online: 5 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02959.x

      While kidney transplantation was feasible in patients with nephrogenic systemic fibrosis, it did not provide any additional benefits in the skin manifestations as compared to dialysis dependent patients.

    4. You have free access to this content
      Impact of Subclinical Inflammation on the Development of Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients (pages 563–570)

      R. L. Heilman, Y. Devarapalli, H. A. Chakkera, K. L. Mekeel, A. A. Moss, D. C. Mulligan, M. J. Mazur, K. Hamawi, J. W. Williams and K. S. Reddy

      Article first published online: 1 FEB 2010 | DOI: 10.1111/j.1600-6143.2009.02966.x

      • image

      Protocol biopsy findings during the first 4 months after kidney transplantation in a cohort of patients on rapid steroid withdrawal show that patients with earlier subclinical inflammation manifest a significantly higher risk of interstitial fibrosis and tubular atrophy on a subsequent one-year protocol biopsy.

    5. You have free access to this content
      Sotrastaurin, a Novel Small Molecule Inhibiting Protein Kinase C: First Clinical Results in Renal-Transplant Recipients (pages 571–581)

      K. Budde, C. Sommerer, T. Becker, A. Asderakis, F. Pietruck, J. M. Grinyo, P. Rigotti, J. Dantal, J. Ng, M. J. Barten and M. Weber

      Article first published online: 29 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02980.x

      • image
      • image
      • image
      • image
      • image

      Results from the first evaluation of the efficacy and safety of oral sotrastaurin in de-novo renal-transplant recipients suggest longer-term evaluation of sotrastaurin plus tacrolimus is warranted.

    6. You have free access to this content
      Baseline Donor-Specific Antibody Levels and Outcomes in Positive Crossmatch Kidney Transplantation (pages 582–589)

      J. M. Gloor, J. L. Winters, L. D. Cornell, L. A. Fix, S. R. DeGoey, R. M. Knauer, F. G. Cosio, M. J. Gandhi, W. Kremers and M. D. Stegall

      Article first published online: 29 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02985.x

      • image
      • image
      • image
      • image
      • image

      Although the risk for acute ABMR is associated with high baseline DSA level in +XM recipients, the incidence of TG in +XM recipients is similar regardless of baseline DSA level.

    7. You have free access to this content
      The Influence of Induction Therapy on Graft and Patient Survival in Patients with and without Hepatitis C after Liver Transplantation (pages 590–601)

      D. K. Moonka, D. Kim, A. Kapke, K. A. Brown and A. Yoshida

      Article first published online: 2 DEC 2009 | DOI: 10.1111/j.1600-6143.2009.02880.x

      • image
      • image
      • image

      In the UNOS public use database, antibody-based induction therapy was not associated with worse outcomes in liver transplant patients with hepatitis C and appeared beneficial in infected and uninfected patients with renal insufficiency prior to transplant. See editorial by Heimbach and Charlton on page 445.

    8. You have free access to this content
      Liver Transplantation with Grafts from Controlled Donors after Cardiac Death: A 20-Year Follow-up at a Single Center (pages 602–611)

      S. Yamamoto, H. E. Wilczek, F. F. Duraj, C.-G. Groth and B.-G. Ericzon

      Article first published online: 5 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02965.x

      • image
      • image
      • image

      This 20-year follow-up, single-center analysis indicates that the use of liver grafts from controlled donors after cardiac death may be a realizable option to expand the donor liver pool and reduce the existing liver organ shortage.

    9. You have free access to this content
      Intraoperative ‘No Go’ Donor Hepatectomies in Living Donor Liver Transplantation (pages 612–618)

      M. Guba, L. Adcock, C. MacLeod, M. Cattral, P. Greig, G. Levy, D. Grant, K. Khalili and I. D. McGilvray

      Article first published online: 29 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02979.x

      • image
      • image

      This study from a large living donor liver transplant center reviews in detail the reasons underlying no-go donor hepatectomies, and notes that the unpredictable findings will sometimes trigger the team to abort the procedure, despite rigorous preparation.

    10. You have free access to this content
      Harm and Benefits of Primary Liver Resection and Salvage Transplantation for Hepatocellular Carcinoma (pages 619–627)

      A. Cucchetti, A. Vitale, M. Del Gaudio, M. Ravaioli, G. Ercolani, M. Cescon, M. Zanello, M. C. Morelli, U. Cillo, G. L. Grazi and A. D. Pinna

      Article first published online: 29 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02984.x

      • image
      • image
      • image
      • image

      A Markov model developed to investigate this issue found that the balance of benefit and harm is determined by the proportion of HCC candidates, the percentage shifted to hepatic resection, and the expected waiting time.

    11. You have free access to this content
      Concomitant Endothelin-1 Overexpression in Lung Transplant Donors and Recipients Predicts Primary Graft Dysfunction (pages 628–636)

      M. Salama, O. Andrukhova, M. A. Hoda, S. Taghavi, P. Jaksch, G. Heinze, W. Klepetko and S. Aharinejad

      Article first published online: 5 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02957.x

      • image
      • image
      • image
      • image

      Pre-transplant serum ET-1 concentrations in donors and recipients are associated with primary graft dysfunction in lung transplants.

    12. You have free access to this content
      The Incidence of Cancer in a Population-Based Cohort of Canadian Heart Transplant Recipients (pages 637–645)

      Y. Jiang, P. J. Villeneuve, A. Wielgosz, D. E. Schaubel, S. S. A. Fenton and Y. Mao

      Article first published online: 1 FEB 2010 | DOI: 10.1111/j.1600-6143.2009.02973.x

      • image
      • image

      This nation-wide cohort follow-up study demonstrates an excess of incident cases of cancer among 1703 heart transplant recipients in Canada, particularly lymphoma, oral cancer and lung cancer.

    13. You have free access to this content
      Multicenter Analysis of Novel and Established Variables Associated with Successful Human Islet Isolation Outcomes (pages 646–656)

      J. S. Kaddis, J. S. Danobeitia, J. C. Niland, T. Stiller and L. A. Fernandez

      Article first published online: 5 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02962.x

      • image

      Data analysis from 14 islet processing facilities revealed that surgically intact pancreata from hemodynamically stable young donors with elevated BMI, short cold-ischemia time and preserved in UW solution strongly correlated with successful human islet isolation.

    14. You have free access to this content
      Specific Unwillingness to Donate Eyes: The Impact of Disfigurement, Knowledge and Procurement on Corneal Donation (pages 657–663)

      M. Lawlor, I. Kerridge, R. Ankeny, T. A. Dobbins and F. Billson

      Article first published online: 29 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02986.x

      This survey of issues relating to corneal donation found that unwillingness to donate corneas is related to concerns surrounding disfigurement, not the method of procurement, and that donation decisions appear more complex than simple appeals to autonomy.

    15. You have free access to this content
      What Defines a Transplant Surgeon? A Needs Assessment for Curricular Development in Transplant Surgery Fellowship Training (pages 664–674)

      J. Fryer, D. A. DaRosa, E. Wang, L. Han, D. Axelrod, M. Ishitani, T. Baker, R. Knight, R. Sung, J. Magee, E. A. Pomfret and on behalf of the ASTS National Transplant Surgery Curriculum Committee

      Article first published online: 5 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02956.x

      • image

      While there was general agreement between transplant surgery program directors and recent fellowship graduates regarding the adequacy of instruction and relevance of most educational items, there were significant differences in some areas that may reflect the different perspectives of two groups at different phases in their career.

    16. You have free access to this content
      Attitudes of the American Public toward Organ Donation after Uncontrolled (Sudden) Cardiac Death (pages 675–680)

      M. L. Volk, G. J. W. Warren, R. R. Anspach, M. P. Couper, R. M. Merion and P. A. Ubel

      Article first published online: 1 FEB 2010 | DOI: 10.1111/j.1600-6143.2009.02971.x

      • image

      This nationwide survey of the general public found Americans to be slightly more willing to donate after cardiac death than brain death, and generally supportive of programs for donation after sudden cardiac death.

  8. Brief Communication

    1. Top of page
    2. The AJT Report
    3. Editorials
    4. Minireview
    5. Meeting Reports
    6. Special Article
    7. Laboratory Science
    8. Clinical Science
    9. Brief Communication
    10. Case Reports
    11. Letters to the Editor
    1. You have free access to this content
      Bortezomib as the Sole Post-Renal Transplantation Desensitization Agent Does Not Decrease Donor-Specific Anti-HLA Antibodies (pages 681–686)

      R. Sberro-Soussan, J. Zuber, C. Suberbielle-Boissel, S. Candon, F. Martinez, R. Snanoudj, M. Rabant, N. Pallet, D. Nochy, D Anglicheau, M. Leruez, A. Loupy, E. Thervet, O. Hermine and C. Legendre

      Article first published online: 1 FEB 2010 | DOI: 10.1111/j.1600-6143.2009.02968.x

      • image
      • image

      Bortezomib used as the sole desensitization therapy in four renal transplant recipients experiencing sub-acute antibody-mediated rejection with persisting DSA did not significantly decrease DSA MFI within the 150-day post-treatment period in any patient. See editorial by Kirk on page 447.

  9. Case Reports

    1. Top of page
    2. The AJT Report
    3. Editorials
    4. Minireview
    5. Meeting Reports
    6. Special Article
    7. Laboratory Science
    8. Clinical Science
    9. Brief Communication
    10. Case Reports
    11. Letters to the Editor
    1. You have free access to this content
      Disseminated Histoplasmosis Associated with Hemophagocytic Lymphohistiocytosis in Kidney Transplant Recipients (pages 687–691)

      M. M. Lo, J. Q. Mo, B. P. Dixon and K. A. Czech

      Article first published online: 1 FEB 2010 | DOI: 10.1111/j.1600-6143.2009.02969.x

      • image

      Hemophagocytic lymphohistiocytosis (HLH), secondary to disseminated histoplasmosis, in two renal transplant recipients resolved with anti-fungal therapy and reduced immunosuppression.

    2. You have free access to this content
      Total Duodenectomy with Enteric Duct Drainage: A Rescue Operation for Duodenal Complications Occurring after Pancreas Transplantation (pages 692–697)

      U. Boggi, F. Vistoli, M. Del Chiaro, C. Moretto, C. Croce, S. Signori, S. D’Imporzano, G. Amorese, D. Campani, F. Calabrese, E. Capocasale and P. Marchetti

      Article first published online: 29 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02981.x

      • image
      • image
      • image

      In the absence of abdominal sepsis, total duodenectomy with dual duct drainage may be used to rescue pancreas grafts with duodenal segment complications that cannot be treated conservatively.

    3. You have free access to this content
      Complex Arterial Reconstruction in Multivisceral Transplantation (pages 698–701)

      R. Girlanda, C. S. Desai, C. S. Matsumoto, S. S. Kaufman, C. A. Little and T. M. Fishbein

      Article first published online: 29 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02982.x

      • image
      • image
      • image

      A multivisceral graft with unusual arterial anatomy was successfully transplanted by anastomosing four separate arteries.

  10. Letters to the Editor

    1. Top of page
    2. The AJT Report
    3. Editorials
    4. Minireview
    5. Meeting Reports
    6. Special Article
    7. Laboratory Science
    8. Clinical Science
    9. Brief Communication
    10. Case Reports
    11. Letters to the Editor
    1. You have free access to this content
      Medium-Term Outcome of an ABO Incompatible Lung Transplant (pages 702–703)

      M. Patel, M. Carby, A. Rice, D. Cummins and N. R. Banner

      Article first published online: 16 FEB 2010 | DOI: 10.1111/j.1600-6143.2009.02863.x

      • image
    2. You have free access to this content
      In Response to: Testa et al. ‘Elective Surgical Patients as Living Organ Donors: A Clinical and Ethical Innovation’ (pages 704–705)

      E. J. Gordon, J. Frader, A. M. Goldberg, D. Penrod, G. McNatt and J. Franklin

      Article first published online: 23 DEC 2009 | DOI: 10.1111/j.1600-6143.2009.02946.x

    3. You have free access to this content

SEARCH

SEARCH BY CITATION